Source: Eur Respir J, 52 (4) 1801718; 10.1183/13993003.01718-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ian M. Adcock, Sharon Mumby, Gaetano Caramori. Breaking news: DNA damage and repair pathways in COPD and implications for pathogenesis and treatment. Eur Respir J, 52 (4) 1801718; 10.1183/13993003.01718-2018

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Hypoxia-induced responses to mimic ongoing remodelling processes in chronic lung diseases Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Modifying remodelling and repair in ILD: a new therapeutic approach? Source: Annual Congress 2006 - PG15 - Remodelling and repair in lung disease Year: 2006 Lung ageing and COPD: is there a role for ageing in abnormal tissue repair? Source: Eur Respir Rev, 26 (146) 170073; 10.1183/16000617.0073-2017 Year: 2017 Are genetic defects of dienin a key link in the pathogenesis of COPD? Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Chronic lung diseases: prospects for regeneration and repair Source: Eur Respir Rev, 30 (159) 200213; 10.1183/16000617.0213-2020 Year: 2021 Pulmonary senescence in chronic obstructive pulmonary disease is primarily mediated by persistent DNA double strand breaks Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 The role of antioxidant enzymes in the pathogenesis of asthma and the formation of the features of its clinical course Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Late Breaking Abstract - Biological phenotypes of ARDS show differential expression of genes involved in oxidative phosphorylation and immunomodulation: an illustration for the need of personalized medicine in ARDS. Source: International Congress 2018 – Ventilation and lung imaging in critically ill patients Year: 2018 Inflammatory pathways in COPD. What we know and potential clinical implications Source: Annual Congress 2008 - New insights into COPD pathophysiology Year: 2008 DNA damage as a molecular link in the pathogenesis of COPD in smokers Source: Eur Respir J 2012; 39: 1368-1376 Year: 2012 Late Breaking Abstract: An animal model for studies on pathogenesis and pharmaceutical intervention of chronic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Targeting repair in lung diseases Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005 Disrupted alveolar repair in COPD: lessons from patient studies and models systems Source: International Congress 2018 – Pathophysiology of the human lung alveolus Year: 2018 Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019 Year: 2020 Modified sensitivity of alveolar cells to TRAIL-mediated apoptosis: a mechanism involved in emphysema pathogenesis with a potential impact on cancer therapy research Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009 Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity Source: Annual Congress 2008 - Physiological year in review Year: 2008 The role of oxidative damage in pathogenesis of experimental pulmonary emphysema Source: Annual Congress 2007 - Unravelling molecular mysteries of COPD Year: 2007